ResMed, Inc. (RMD)
206.92
-2.72
(-1.30%)
USD |
NYSE |
May 07, 16:00
207.00
+0.08
(+0.04%)
Pre-Market: 05:28
ResMed Research and Development Expense (Annual) : 331.28M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Abbott Laboratories | 2.889B |
| Baxter International, Inc. | 503.00M |
| Boston Scientific Corp. | 2.052B |
| Intuitive Surgical, Inc. | 1.312B |